Opportunity ID: 343483

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-250
Funding Opportunity Title: Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Sep 14, 2022
Last Updated Date: Sep 21, 2022
Original Closing Date for Applications: Jan 30, 2025
Current Closing Date for Applications: Jan 30, 2025
Archive Date: Mar 07, 2025
Estimated Total Program Funding:
Award Ceiling: $1,500,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Nonprofits Other Than Institutions of Higher Education
Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

Additional Information

Agency Name: National Institutes of Health
Description:

The National Institute of General Medical Sciences (NIGMS) invites applications for renewal of eligible Centers of Biomedical Research Excellence (COBRE) grants. The objective of the COBRE initiative is to strengthen an institution’s biomedical research infrastructure through the establishment of a thematic, multi-disciplinary center and to enhance the ability of investigators to compete independently for NIH individual research grants or other external peer-reviewed support. COBRE awards are supported through the Institutional Development Award (IDeA) Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH. The goal of this FOA is to support existing COBRE Phase 1 Centers by further strengthening the research infrastructure and to continue the development and support of a critical mass of investigators with the expertise in the Center’s scientific interest areas.

Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-22-250.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date
updated eligibility Sep 21, 2022
Sep 14, 2022

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-250
Funding Opportunity Title: Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Sep 14, 2022
Last Updated Date: Sep 21, 2022
Original Closing Date for Applications: Jan 30, 2025
Current Closing Date for Applications: Jan 30, 2025
Archive Date: Mar 07, 2025
Estimated Total Program Funding:
Award Ceiling: $1,500,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Nonprofits Other Than Institutions of Higher Education
Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

Additional Information

Agency Name: National Institutes of Health
Description:

The National Institute of General Medical Sciences (NIGMS) invites applications for renewal of eligible Centers of Biomedical Research Excellence (COBRE) grants. The objective of the COBRE initiative is to strengthen an institution’s biomedical research infrastructure through the establishment of a thematic, multi-disciplinary center and to enhance the ability of investigators to compete independently for NIH individual research grants or other external peer-reviewed support. COBRE awards are supported through the Institutional Development Award (IDeA) Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH. The goal of this FOA is to support existing COBRE Phase 1 Centers by further strengthening the research infrastructure and to continue the development and support of a critical mass of investigators with the expertise in the Center’s scientific interest areas.

Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-22-250.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information

grantsinfo@nih.gov
Email:grantsinfo@nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-250
Funding Opportunity Title: Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.859 — Biomedical Research and Research Training
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 14, 2022
Last Updated Date: Sep 14, 2022
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 30, 2025
Archive Date: Mar 07, 2025
Estimated Total Program Funding:
Award Ceiling: $1,500,000
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The National Institute of General Medical Sciences (NIGMS) invites applications for renewal of eligible Centers of Biomedical Research Excellence (COBRE) grants. The objective of the COBRE initiative is to strengthen an institution’s biomedical research infrastructure through the establishment of a thematic, multi-disciplinary center and to enhance the ability of investigators to compete independently for NIH individual research grants or other external peer-reviewed support. COBRE awards are supported through the Institutional Development Award (IDeA) Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH. The goal of this FOA is to support existing COBRE Phase 1 Centers by further strengthening the research infrastructure and to continue the development and support of a critical mass of investigators with the expertise in the Center’s scientific interest areas.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-22-250.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Folder 343483 Full Announcement-PAR-22-250 -> PAR-22-250-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00276764 Dec 30, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or before January 24, 2025 PKG00277505 Dec 30, 2022 Jan 24, 2025 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00289296 Dec 02, 2024 Jan 30, 2025 View

Package 1

Mandatory forms

343483 RR_SF424_5_0-5.0.pdf

343483 PHS398_CoverPageSupplement_5_0-5.0.pdf

343483 RR_OtherProjectInfo_1_4-1.4.pdf

343483 PerformanceSite_4_0-4.0.pdf

343483 RR_KeyPersonExpanded_4_0-4.0.pdf

343483 PHS398_ResearchPlan_4_0-4.0.pdf

343483 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343483 PHS_Additional_IndirectCosts_2_0-2.0.pdf

343483 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

343483 RR_SF424_5_0-5.0.pdf

343483 PHS398_CoverPageSupplement_5_0-5.0.pdf

343483 RR_OtherProjectInfo_1_4-1.4.pdf

343483 PerformanceSite_4_0-4.0.pdf

343483 RR_KeyPersonExpanded_4_0-4.0.pdf

343483 PHS398_ResearchPlan_5_0-5.0.pdf

343483 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343483 PHS_Additional_IndirectCosts_2_0-2.0.pdf

343483 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

343483 RR_SF424_5_0-5.0.pdf

343483 PHS398_CoverPageSupplement_5_0-5.0.pdf

343483 RR_OtherProjectInfo_1_4-1.4.pdf

343483 PerformanceSite_4_0-4.0.pdf

343483 RR_KeyPersonExpanded_4_0-4.0.pdf

343483 PHS398_ResearchPlan_5_0-5.0.pdf

343483 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343483 PHS_Additional_IndirectCosts_2_0-2.0.pdf

343483 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T17:00:27-05:00

Share This Post, Choose Your Platform!

About the Author: